FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 2122978 · Received June 9, 2011

Report

Report Number
2953161-2011-00134
Event Type
Injury
Date Received
June 9, 2011
Date of Event
May 11, 2011
Report Date
June 9, 2011
Manufacturer
W. L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE MANUFACTURING PAPERWORK HAS BEEN CONDUCTED. THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. AS STATED IN THE GORE EXCLUDER AAA ENDOPROSTHESIS INSTRUCTIONS FOR USE, THE SAFETY AND EFFECTIVENESS OF THE GORE EXCLUDER AAA ENDOPROSTHESIS HAVE NOT BEEN EVALUATED IN PATIENT POPULATIONS WITH LEAKING (PENDING RUPTURE OR RUPTURED) ANEURYSMS.

Description of Event or Problem · 1

ON (B)(6), 2011, THE PATIENT WAS TREATED EMERGENTLY FOR A RUPTURING ABDOMINAL AORTIC ANEURYSM MEASURING ABOUT 9 CM, AND WAS IMPLANTED WITH THREE GORE EXCLUDER AAA ENDOPROSTHESIS. FINAL ANGIOGRAPHY SHOWED NO EVIDENCE OF ENDOLEAK. THE PATIENT TOLERATED THE PROCEDURE WELL. ON (B)(6), 2011, THE PATIENT EXPERIENCED A HOT BELLY AND WAS TREATED FOR SEPSIS. ANTIBIOTICS WERE ADMINISTERED AT THAT TIME. ON (B)(6), 2011, THE PATIENT WAS CONVERTED TO OPEN SURGICAL REPAIR TO TREAT AN ABDOMINAL INFECTION. THE INFECTED GORE EXCLUDER AAA ENDOPROSTHESES WERE EXPLANTED. THE PATIENT WAS STABLE UPON COMPLETION. ON (B)(6), 2011, THE PATIENT WAS SEEN ON A FOLLOW-UP VISIT AND WAS DOING WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES WLG425 7408649

Patients

Seq Age Sex Outcome Treatment
1 62 YR Hospitalization| O| R (B)(4)| (B)(4)